Screener
Crinetics Pharmaceuticals CRNX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Investment securities, amortized cost of $1,178,076 at March 31, 2026 and $924,317 at December 31, 2025 | 1,176,965 | 926,353 |
| Trade accounts receivable, net | 5,683 | 592 |
| Inventory | 3,064 | 2,022 |
| Prepaid expenses and other current assets | 22,361 | 17,839 |
| Total current assets | 1,322,414 | 1,048,342 |
| Property and equipment, net | 13,497 | 14,296 |
| Operating lease right-of-use assets | 39,790 | 40,492 |
| Restricted cash, net of current portion | 800 | 800 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's prepaid & other current?
- Crinetics Pharmaceuticals (CRNX) reported prepaid & other current of $22.36M in Q1 2026.
- How has Crinetics Pharmaceuticals's prepaid & other current changed year-over-year?
- Crinetics Pharmaceuticals's prepaid & other current increased by 36.1% year-over-year, from $16.43M to $22.36M.
- What is the long-term trend for Crinetics Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's prepaid & other current has grown at a 22.0% compound annual growth rate (CAGR), from $6.61M to $17.84M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Crinetics Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude